Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Archives of Neurology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.63.2.299-BPMID 16476828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathological gambling caused by drugs used to treat Parkinson disease.

  2005cited by this paper
• Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem

  2004cited by this paper
• Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database

  2002cited by this paper

• Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.

  2018cites this paper
• Sexual Dysfunctions in Parkinson's Disease: An Underrated Problem in a Much Discussed Disorder.

  2017cites this paper
• Decision-Making and Impulse Control Disorders in Parkinson's Disease

  2017cites this paper
• Use of data mining at the Food and Drug Administration

  2016cites this paper
• Publicity and reports of behavioral addictions associated with dopamine agonists

  2015cites this paper
• Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy

  2015cites this paper
• Imprinted genes, impulsivity and risk-taking

  2014cites this paper
• Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration’s Adverse Event database

  2014cites this paper
• Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task

  2013cites this paper
• Kliniczne znaczenie blokowania receptora NMDA

  2013cites this paper
• Non-motor and neuropsychiatric features of Parkinson's disease

  2013cites this paper
• Pathological gambling in Parkinson's disease. A comprehensive review.

  2013cites this paper
• Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice.

  2013cites this paper
• Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's Disease and other disorders.

  2012cites this paper
• Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

  2012cites this paper
• Behavioral mechanisms of pramipexole-induced impulsivity: Discrimination processes underlying decision-making

  2012cites this paper
• Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review.

  2012cites this paper
• Hipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casos

  2011cites this paper
• PATHOLOGIC GAMBLING OR HYPERSEXUALITY AFTER PD TREATMENT For personal use . Mass reproduce only with permission from Mayo Clinic Proceedings

  2011cites this paper
• JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab

  2010cites this paper
• Insights into pathophysiology of punding reveal possible treatment strategies

  2010cites this paper
• Effects of pramipexole on impulsive choice in male wistar rats.

  2010cites this paper
• Genetic and environmental influences on disordered gambling in men and women.

  2010cites this paper
• Pathological gambling in Parkinson disease is reduced by amantadine

  2010cites this paper
• Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.

  2009cites this paper
• Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease

  2009cites this paper
• Dopaminergic Modulation of Risk-Based Decision Making

  2009cites this paper
• Approche épidémiologique et évaluative des comportements addictifs

  2009cites this paper
• Effects of acute pramipexole on preference for gambling-like schedules in male Wistar rats

  2009cites this paper
• Personality, addiction, dopamine: insights from Parkinson's disease.

  2009cites this paper
• Personality , Addiction , Dopamine : Insights from Parkinson ’ s Disease

  2009cites this paper
• Impulse Control Disorders Arising in 3 Patients Treated With Rotigotine

  2009cites this paper
• The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

  2008cites this paper
• Antiparkinsonian Medication and Pathological Gambling

  2008cites this paper
• Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.

  2008cites this paper
• Cognitive and behavioural impairment in Parkinson's disease

  2008cites this paper
• Prevalence of Problem and Pathological Gambling in Parkinson’s Disease

  2008cites this paper
• DOPAMINERGIC MODULATION OF RISK-BASED DECISION MAKING

  2008cites this paper
• Impulse Control Disorders and Pathological Gambling in Patients With Parkinson Disease

  2008cites this paper
• Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series

  2007cites this paper
• Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.

  2007cites this paper
• Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

  2007cites this paper
• Calculating utility: preclinical evidence for cost–benefit analysis by mesolimbic dopamine

  2007cites this paper
• Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease

  2007cites this paper
• Pramipexole in psychiatry: a systematic review of the literature.

  2007cites this paper
• Pathological gambling associated with dopamine agonist use in restless legs syndrome.

  2007cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2006cites this paper